Vir Biotechnology Inc. Tops Q3 EPS by 172c

  • Investing.com
Vir Biotechnology Inc. Tops Q3 EPS by 172c

Vir Biotechnology Inc. (VIR) reported Q3 EPS of $1.30, $1.72 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $374.6 million versus the consensus estimate of $146.35 million.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles